|
Presented by
Warren and Katharine Schlinger Professor of Chemical Engineering
California Institute of Technology
Mark E. Davis is the Warren and Katharine Schlinger Professor of Chemical Engineering at the California Institute of Technology and a member of the Experimental Therapeutics Program of the Comprehensive Cancer Center at the City of Hope. He has over 350 scientific publications, two textbooks and over 50 patents.
Professor Davis is a founding editor of CaTTech and has been an associate editor of Chemistry of Materials and the AIChE Journal. He is the recipient of numerous awards including the Colburn and Professional Progress Awards from the AIChE and the Ipatieff, Langmuir and Murphree Prizes from the ACS. Professor Davis was the first engineer to win the NSF Alan T. Waterman Award. He was elected in the National Academy of Engineering in 1997 and the National Academy of Sciences in 2006.
Professor Davis’ research efforts involve materials synthesis in two general areas; namely, zeolites and other solids that can be used for molecular recognition and catalysis, and polymers for the delivery of a broad range of therapeutics. He is the founder of Insert Therapeutics Inc., a company that focused on the use of cyclodextrin-containing polymers for drug delivery applications and Calando Pharmaceuticals, Inc. a company based in Pasadena, CA USA that created the first RNAi therapeutic to reach the clinic for treating cancer.\ He has been a member of the scientific advisory boards of Symyx (Nasdaq: SMMX) and Alnylam (Nasdaq: ALNY).
Professor Davis has achieved All American Status for Masters Track and Field in both the 400 Meter and 200 Meter Dashes.
|